{"nct_id":"NCT05552222","title":"A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-10-25","start_date_type":"ACTUAL","primary_completion_date":"2031-04-30","primary_completion_date_type":"ESTIMATED","completion_date":"2033-10-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}